DLX vs MRK · P/E 13, rev $499.3M vs P/E 33, rev $16.61B
Deluxe Corporation (DLX) versus Merck & Company Inc (MRK) — a side-by-side from cached financials, not a winner call.
Deluxe Corporation (DLX) is a conglomerates company listed on US.
Merck & Company Inc (MRK) is a drug manufacturers - general company listed on NYSE. It is led by Rob Davis.
Latest reported DLX revenue for 2026-06-30 was $499.3M. Net income was $19.1M. Revenue was down 7.2% from 2026-03-31 to 2026-06-30. DLX currently screens at market cap $709.7M and trailing P/E 12.7.
Latest reported MRK revenue for 2026-06-30 was $16.61B. Net income was -$1.33B. Revenue was up 2.0% from 2026-03-31 to 2026-06-30. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
DLX currently screens at market cap $709.7M and trailing P/E 12.7. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
Not investment advice. Open the DLX and MRK stock pages for the full models.
Not investment advice.